Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Goal: Protect patients, satisfy legal and regulatory duties, preserve the company’s long‑term credibility, and manage the short‑term market shock as responsibly as possible. Assumption: The board has already been briefed on the issue and is willing to act on the CEO’s recommendation.Read the full answer
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer